Literature DB >> 330815

Growth of two strains of Mycobacterium bovis (BCG) in athymic mice.

K Takeya, K Nomoto, S Muraoka, S Shimotori, T Taniguchi, T Miyake.   

Abstract

Entities:  

Mesh：

Year:  1977        PMID： 330815     DOI： 10.1099/00221287-100-2-403

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN： 0022-1287


× No keyword cloud information.
  8 in total

1.  Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.

Authors:  Yasushi Ami; Yasuyuki Izumi; Kazuhiro Matsuo; Kenji Someya; Masaru Kanekiyo; Shigeo Horibata; Naoto Yoshino; Koji Sakai; Katsuaki Shinohara; Sohkichi Matsumoto; Takeshi Yamada; Shudo Yamazaki; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  Striking the right balance; the role of cytokines in mycobacterial disease.

Authors:  C Moreno; A J Rees
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

3.  Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.

Authors:  K Yamamoto; K Kato; M Kakinuma; H Okuyama; I Azuma
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

4.  Cell-mediated immune responses in mice infected with Fonsecaea pedrosoi.

Authors:  N Kurita
Journal:  Mycopathologia       Date:  1979-08-31       Impact factor: 2.574

5.  Adoptive immunity to Mycobacterium bovis strain bacillus Calmette-Guérin by long-term cultured T-cell line in nude mice.

Authors:  S Yamamoto; H Iwai; K Ueda
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

6.  I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages.

Authors:  G A Rook; B R Champion; J Steele; A M Varey; J L Stanford
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

7.  Mycobacterium bovis Bacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease Control.

Authors:  Kazuhiro Matsuo; Yasuhiro Yasutomi
Journal:  Tuberc Res Treat       Date:  2011-05-24

8.  Evidence for an alpha/beta T cell-independent mechanism of resistance to mycobacteria. Bacillus-Calmette-Guerin causes progressive infection in severe combined immunodeficient mice, but not in nude mice or in mice depleted of CD4+ and CD8+ T cells.

Authors:  A A Izzo; R J North
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.